Stock News & Analysis

One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.

The chipmaker has had a great year, but its stock has risen too far, too fast.

Both funds charge just 0.03% in expenses, but BND offers broader corporate and government bond exposure while VGIT focuses solely on U.S. Treasuries with lower volatility.

Investors shouldn't conflate the devaluation of fiat currencies with rising Treasury yields.

Tesla's third-quarter deliveries were impressive, but investors will focus on gross margin when full results come out.

Global X's midstream fund delivered $2,531 on a $1,000 investment over five years, while Invesco's solar play returned just $565 despite higher fees.

The LEO satellite producer still isn't generating recurring commercial revenue yet.

The reason why Microsoft isn't valued at the same premium as its big tech peers has to do with its AI strategy.

The AI data analytics company's stock is extremely pricey.

There are only a few weeks left in the year, so act fast.

USA Rare Earth is making major investments as it seeks to become a leading domestic producer of permanent magnets.

Alphabet has quickly become one of Berkshire's largest holdings.

Buying entire baskets of stocks still makes for smart, instant diversification. But don't look past an obvious opportunity by insisting that only marketwide diversification is beneficial.

American Express and Coca-Cola turned into big winners thanks to Buffett's buy-and-hold approach; Bank of America and Chevron could be next.

Things were looking much better a year ago.

Each company stands to benefit from booming cloud growth in its own way.

IonQ and Rigetti get all the quantum computing headlines, but these three stocks might be better positioned to outperform this fall.

The mREIT pays a massive dividend, but its stock price decline is erasing those gains.

The nuclear energy company faces daunting near-term challenges.

Only one of these looks like a buy to me.